title: Use of reduced dose of OKT3 (2.5 mg) after renal transplantation.
authors.affiliation: Escola Paulista de Medicina, UNIFESP, Sao Paulo, Brazil.
authors.forename: P G P
authors.initials: PG
authors.lastname: Machado
authors.forename: H S
authors.initials: HS
authors.lastname: Tedesco
authors.forename: R G
authors.initials: RG
authors.lastname: Silva
authors.forename: A
authors.initials: A
authors.lastname: Pacheco-Silva
authors.forename: J O P
authors.initials: JO
authors.lastname: Medina
mesh_terms: D000208:Acute Disease; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D012086:Reoperation; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D017211:Treatment Failure
chemical_list: D016853:Muromonab-CD3; D016559:Tacrolimus